Indian Journal of Clinical Biochemistry

, Volume 20, Issue 2, pp 189–191 | Cite as

Incidence of microalbuminuria in tobacco chewers

  • Hitesh Shah


It is well established that smoking increases the risk for cardiovascular disease. From the studies in diabetic subjects it has been shown that smoking induces microalbuminuria and accelerates the progression to end stage renal disease. Little is known whether smoking is also related to microalbuminuria and renal end organ damage in non diabetic subjects. The hypothesis which was put forward that tobacco chewing is related to microalbuminuria and renal functional changes in non diabetic subjects. We therefore performed a population based study in the Anand city of Gujarat in which we studied the relation between tobacco chewing and urinary albumin excretion. Tobacco chewers had a higher urinary albumin excretion (Albumin excretion 373±13.9 mg/day: P<0.01) than those who do not consume tobacco. In conclusion tobacco chewing is associated with albuminuria.

Key words

Microalbuminuria Urinary albumin excretion (UAE) 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    The Health consequences of smoking publication 73-8704. Behesde Md. US Dept. of education and welfare public health service (1973).Google Scholar
  2. 2.
    Mammond, E.C. (1966) Smoking is relation to the death rates of one million men and women. In Epidemiological approaches to the study of cancer and other disease Haenazel W. Ed. National cancer institute monograph 19. Bethesda Md US Deptl of Health Education and Welfare Public Health Service, 127–204.Google Scholar
  3. 3.
    Orth, S.R., Ritz, E. and Schrier, R. (1997) The renal risk of smoking. Kidney int. 51, 1669, 77.PubMedCrossRefGoogle Scholar
  4. 4.
    Metcalf, P.A., Baker, J.R., Scragg, P.K.R., Dryson, E., Scolt, A.J. and Wild, C.J. (1993) Albuminuria in people at least 40 years old: effect of alcohol consumption regular exercise and cigeratte smoking. Clin. Chem. 93/9, 97.Google Scholar
  5. 5.
    Cirillo, M., Sennigalliesi, L., Laurenzi, M., Alfieri, R., stamler, J., Stamler, al. (1998) Microalbuminuria in non diabetic adults. Arch. Intern. Med. 158, 1933–1939.PubMedCrossRefGoogle Scholar
  6. 6.
    Jensen, T., Stender, S. and Decker, T. (1988) Abnormalities in plasma concentration of lipoproteins and fibrinogen in type 1 (Insulin dependent) diabetic patients with increase urinary albumin excretion. Diabetologia 31, 142–145.PubMedCrossRefGoogle Scholar
  7. 7.
    Niskanen, L., Uusitupa, M., Sarland, H., Siltonen, O., Voutilaimne, E. and Penthia, I. (1990) Microalbuminuria predicts the development of serum lipoprotein abnormalities favoring atherogenesis is newly diagnosed type 2 (non insulin dependent) diabetic patients. Diabetologia 33, 237–243.PubMedCrossRefGoogle Scholar
  8. 8.
    Jarrett, R.J., Viberto, G.C., Angyropoulos, A., Hill, R.D., Mahmud, U. and Murreis, T.J. (1984) Microabluminuria predicts mortality in non insulin dependent diabetes. Dibet. Med. 1, 17–19.CrossRefGoogle Scholar
  9. 9.
    Reddi, A.S. and Camerini Davalos, R.A. (1990) Diabetic nephropathy an update. Arch. Intern. Med. 150, 31–43.PubMedCrossRefGoogle Scholar
  10. 10.
    Kuuuuusiosto, J., Mykkanem, L., Pyoralc, K. and Laakso, M. (1995) Hyperinsulinemic microalbumin. A new risk idicator for coronary heart disease. Circulation 91, 831–837.Google Scholar
  11. 11.
    Walanabe, N., Kamed, S., Ohkubo, A., Yamanake, M. and Oshawa, S. (1986) Clin. Chem. 32, 1551.Google Scholar
  12. 12.
    Barters, M. and Bohmer, M. (1972) Clin. Chem. Aeta. 37, 193.CrossRefGoogle Scholar
  13. 13.
    Schirmeister, J., Willmann, H. and Kiefer, H. (1964) Disch. Med. Wascher 89, 1018.CrossRefGoogle Scholar
  14. 14.
    Talke, H. and Schubert, G.E. (1965) Klin 43, 174.CrossRefGoogle Scholar
  15. 15.
    Tinder P. Annals (1969) Clin. Biochem. 6, 24.Google Scholar
  16. 16.
    Young, al. (1975) Clin. Chem. 21, ID.Google Scholar
  17. 17.
    Bengmayer, H.V. (1974) Methods of enzymatic Analysis. A.P. Ny, 1196.Google Scholar
  18. 18.
    Gosling, P. and Beavers, D.G. (1989) Urinary albumin excretion and blood pressure in general population. Clin. Sci. 76, 39–42.PubMedGoogle Scholar
  19. 19.
    Winocur, P.H., Harland, Jo, Miher, M.F., Lahar, M.F. and Alberti, K.G. (1992) Microalbuminuria and associated cardiovascular risk factors in the community. Atherosclerosis 93, 71–81.CrossRefGoogle Scholar
  20. 20.
    Brown, M.S. Goldstein (1983) JIthe hyperlipoproteininemias and other disorders of lipid metabolism editors Harrison’s principle of internal mdicine New York MC Graw Hill, 547–559.Google Scholar
  21. 21.
    Telmer, S., Christensen, J.S., Anderson, A.R. and Herup, J. (1984) Smoking habits and prevalence of clinical microangiopathy in insulin dependent diabetics. Aeta. Med. Scand. 215, 53–68.Google Scholar
  22. 22.
    Stegmayr, B. and Lithner, F. (1987) Tobacco and end stage diabetic nephropathy. Br. Med. J. 295, 53–68.Google Scholar
  23. 23.
    Muhilhauser, I., Sawicki, P. and Berger, M. (1986) Cigarette smoking as a risk factor for Macroproteinuria and proliferative retionpathy in type I (Insulin dependent) diabetes. Diabetologic 29, 500–502.CrossRefGoogle Scholar
  24. 24.
    Chase, H.P., Garg, S.K., Marshall, G., Berg, C.L., Harris, S., Jackson, al. (1991) cigeratte smoking increases the risk of albuminuria among subjects with type I diabetes. J. Am. Med. Asso. (JAMA) 265, 614–617.CrossRefGoogle Scholar
  25. 25.
    Redehill, A., Fianco, Cerecedo A., Hemseu, A., Stensdotter, M. Pernow, J. and Lundberg, J.M. (1989). Cigeratte smoking Induced elevation of plasma neuropeptide Y levels in humns. Clin. Physiol. 9, 243–248.Google Scholar

Copyright information

© Association of Clinical Biochemists of India 2005

Authors and Affiliations

  1. 1.Department of Biochemistry, Pramukh Swami Medical CollegeShri Krishna Hospital and H.M. Patel Centre For Medical Care & EducationGujaratIndia

Personalised recommendations